A market reopening after fourteen years, where nobody has a current distributor list and the pre-conflict one no longer describes reality. We hold analyst-verified profiles of pharmaceuticals, medical devices, diagnostics, consumables and MedTech distributors in Syria, scored against your specific brief by AI that reads what you are selling and weights the criteria accordingly. The fieldwork is done. You build the shortlist.
There is no reliable published list of pharmaceuticals, medical devices, diagnostics, consumables and MedTech distributors in Syria. Commercial directories are thin and out of date, trade association membership tells you who pays dues rather than who performs, and the companies easiest to find are the ones with the best marketing rather than the best operations.
Route security, surviving warehousing and port access determine real reach. All three should be tested rather than assumed. Most international sanctions were lifted between 2025 and 2026, but targeted designations and export controls remain and screening is a continuing obligation. Working all of that out from scratch is six weeks of desk research and a shortlist you cannot fully defend. It is the reason this work has traditionally cost what it costs.
The same fifty-plus field structure used across every market on Hub, with the fields that actually predict performance in healthcare weighted for this sector.
Built for commercial directors and market access leads at manufacturers preparing an entry or reviewing an incumbent. Tell us the product and the channel, and we will open your access to Syria healthcare.